Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...

Guillain-Barré Syndrome occurs when the body’s immune system mistakenly attacks nerve cells, disrupting communication between ...

Konica Minolta Healthcare Americas, Inc., is pleased to announce the publication of a case study by clinicians in the ...